HighVista Strategies »

Brink's Company shares owned by HighVista Strategies

Quarter-by-quarter ownership of Brink's Company (BCO) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Brink's Company

Tip: Access up to 7 years of quarterly data

All positions including Brink's Company held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brink's Company by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 16k 94.49

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Definium Therapeutics Com Shs (DFTX)
Immunovant (IMVT)
Praxis Precision Medicines I Com New (PRAX)
Relay Therapeutics (RLAY)
Alkermes SHS (ALKS)
Vaxcyte (PCVX)
Tango Therapeutics (TNGX)
Liquidia Corporation Com New (LQDA)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)
Enliven Therapeutics (ELVN)
Amylyx Pharmaceuticals (AMLX)

View all positions for HighVista Strategies

Top funds holding Brink's Company

FMR
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Robeco Investment Management
LSV Asset Management
American Century Companies
Geode Capital Management
Hanna Zanoni
Simcoe Capital Management
Fourth Sail Capital
Turtle Creek Asset Management
Ariel Investments
First Trust Advisors

View all funds holding Brink's Company